Macrophage Exosomes Resolve Atherosclerosis by Regulating Hematopoiesis and Inflammation via MicroRNA Cargo

Laura Bouchareychas,Phat Duong,Sergio Covarrubias,Eric Alsop,Tuan Anh Phu,Allen Chung,Michael Gomes,David Wong,Bessie Meechoovet,Allyson Capili,Ryo Yamamoto,Hiromitsu Nakauchi,Michael T McManus,Susan Carpenter,Kendall Van Keuren-Jensen,Robert L Raffai
DOI: https://doi.org/10.1016/j.celrep.2020.107881
2020-07-14
Abstract:Developing strategies that promote the resolution of vascular inflammation and atherosclerosis remains a major therapeutic challenge. Here, we show that exosomes produced by naive bone marrow-derived macrophages (BMDM-exo) contain anti-inflammatory microRNA-99a/146b/378a that are further increased in exosomes produced by BMDM polarized with IL-4 (BMDM-IL-4-exo). These exosomal microRNAs suppress inflammation by targeting NF-κB and TNF-α signaling and foster M2 polarization in recipient macrophages. Repeated infusions of BMDM-IL-4-exo into Apoe-/- mice fed a Western diet reduce excessive hematopoiesis in the bone marrow and thereby the number of myeloid cells in the circulation and macrophages in aortic root lesions. This also leads to a reduction in necrotic lesion areas that collectively stabilize atheroma. Thus, BMDM-IL-4-exo may represent a useful therapeutic approach for atherosclerosis and other inflammatory disorders by targeting NF-κB and TNF-α via microRNA cargo delivery.
What problem does this paper attempt to address?